Caroline Améen

Title: Caroline Améen: Innovator in Cardiac Precursor Cell Research

Introduction

Caroline Améen is a notable inventor based in Gothenburg, Sweden. She has made significant contributions to the field of stem cell research, particularly in the development of multipotent cardiac precursor cells. Her work has implications for in vitro testing and potential therapeutic applications.

Latest Patents

Caroline Améen holds a patent titled "Population of multipotent cardiac precursor cells derived from human blastocysts derived stem cells." This patent discloses a novel population of multipotent cardiac precursor (MCP) cells derived from human blastocyst-derived stem cells. The patent outlines methods for the preparation of these cells and their use in in vitro testing. The MCP cells exhibit unique characteristics, including a characteristic morphology, growing as clusters of small, round, and phase-bright cells. Individual cells range from 5-20 µm in diameter, and each cluster can consist of 2-500 cells. The cells form clusters that can be round or elongated in shape, appearing as loosely adherent clumps. Additionally, they have a relatively high nucleus-to-cytoplasma ratio, typically between 1:2-1:64 of the total cell volume, and they are non-contracting.

Career Highlights

Caroline Améen is associated with Cellectis AB, where she continues her research and development in the field of cardiac precursor cells. Her innovative work has positioned her as a key figure in advancing stem cell technology.

Collaborations

Some of her notable coworkers include Peter Sartipy and Karolina Åkesson, who contribute to the collaborative efforts in her research endeavors.

Conclusion

Caroline Améen's contributions to the field of cardiac precursor cell research highlight her innovative spirit and dedication to advancing medical science. Her patent and ongoing work at Cellectis AB underscore her role as a leading inventor in this important area of study.